Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HCR0
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 7 |
GO:0016874 | ligase activity | 2 | 7 |
GO:0016879 | ligase activity, forming carbon-nitrogen bonds | 3 | 7 |
GO:0016880 | acid-ammonia (or amide) ligase activity | 4 | 7 |
GO:0047479 | trypanothione synthase activity | 5 | 7 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 12 | 14 | PF00675 | 0.463 |
CLV_NRD_NRD_1 | 64 | 66 | PF00675 | 0.440 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.436 |
CLV_PCSK_KEX2_1 | 64 | 66 | PF00082 | 0.440 |
CLV_PCSK_SKI1_1 | 72 | 76 | PF00082 | 0.460 |
DEG_APCC_DBOX_1 | 15 | 23 | PF00400 | 0.293 |
DEG_SPOP_SBC_1 | 126 | 130 | PF00917 | 0.185 |
DOC_CYCLIN_RxL_1 | 69 | 77 | PF00134 | 0.253 |
DOC_MAPK_gen_1 | 12 | 19 | PF00069 | 0.393 |
DOC_PP2B_LxvP_1 | 73 | 76 | PF13499 | 0.240 |
DOC_PP4_FxxP_1 | 172 | 175 | PF00568 | 0.185 |
DOC_SPAK_OSR1_1 | 221 | 225 | PF12202 | 0.345 |
DOC_USP7_MATH_1 | 120 | 124 | PF00917 | 0.248 |
DOC_USP7_MATH_1 | 161 | 165 | PF00917 | 0.254 |
DOC_USP7_UBL2_3 | 146 | 150 | PF12436 | 0.292 |
DOC_WW_Pin1_4 | 116 | 121 | PF00397 | 0.275 |
DOC_WW_Pin1_4 | 171 | 176 | PF00397 | 0.330 |
DOC_WW_Pin1_4 | 95 | 100 | PF00397 | 0.393 |
LIG_14-3-3_CanoR_1 | 16 | 20 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 65 | 75 | PF00244 | 0.254 |
LIG_14-3-3_CterR_2 | 248 | 253 | PF00244 | 0.473 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.649 |
LIG_BRCT_BRCA1_1 | 209 | 213 | PF00533 | 0.310 |
LIG_FHA_1 | 1 | 7 | PF00498 | 0.464 |
LIG_FHA_1 | 230 | 236 | PF00498 | 0.483 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.334 |
LIG_FHA_2 | 16 | 22 | PF00498 | 0.294 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.334 |
LIG_FHA_2 | 237 | 243 | PF00498 | 0.557 |
LIG_LIR_Apic_2 | 171 | 175 | PF02991 | 0.334 |
LIG_LIR_Gen_1 | 232 | 241 | PF02991 | 0.393 |
LIG_LIR_Nem_3 | 174 | 179 | PF02991 | 0.308 |
LIG_LIR_Nem_3 | 232 | 237 | PF02991 | 0.342 |
LIG_LIR_Nem_3 | 49 | 55 | PF02991 | 0.378 |
LIG_Pex14_2 | 172 | 176 | PF04695 | 0.185 |
LIG_Pex14_2 | 62 | 66 | PF04695 | 0.240 |
LIG_SH2_CRK | 209 | 213 | PF00017 | 0.444 |
LIG_SH2_GRB2like | 33 | 36 | PF00017 | 0.362 |
LIG_SH2_NCK_1 | 209 | 213 | PF00017 | 0.411 |
LIG_SH2_STAP1 | 209 | 213 | PF00017 | 0.317 |
LIG_SH2_STAT3 | 25 | 28 | PF00017 | 0.310 |
LIG_SH2_STAT3 | 55 | 58 | PF00017 | 0.240 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.477 |
LIG_SH2_STAT5 | 223 | 226 | PF00017 | 0.350 |
LIG_SH2_STAT5 | 25 | 28 | PF00017 | 0.480 |
LIG_SH2_STAT5 | 47 | 50 | PF00017 | 0.292 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.334 |
LIG_SH2_STAT5 | 89 | 92 | PF00017 | 0.334 |
LIG_SH3_3 | 103 | 109 | PF00018 | 0.326 |
LIG_SUMO_SIM_par_1 | 2 | 10 | PF11976 | 0.697 |
LIG_UBA3_1 | 212 | 219 | PF00899 | 0.270 |
MOD_CK1_1 | 113 | 119 | PF00069 | 0.302 |
MOD_CK1_1 | 171 | 177 | PF00069 | 0.330 |
MOD_CK1_1 | 229 | 235 | PF00069 | 0.245 |
MOD_CK1_1 | 34 | 40 | PF00069 | 0.399 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.682 |
MOD_CK1_1 | 85 | 91 | PF00069 | 0.279 |
MOD_CK2_1 | 236 | 242 | PF00069 | 0.466 |
MOD_Cter_Amidation | 10 | 13 | PF01082 | 0.441 |
MOD_GlcNHglycan | 114 | 118 | PF01048 | 0.553 |
MOD_GlcNHglycan | 209 | 212 | PF01048 | 0.315 |
MOD_GlcNHglycan | 9 | 12 | PF01048 | 0.484 |
MOD_GSK3_1 | 116 | 123 | PF00069 | 0.369 |
MOD_GSK3_1 | 229 | 236 | PF00069 | 0.429 |
MOD_GSK3_1 | 31 | 38 | PF00069 | 0.501 |
MOD_N-GLC_1 | 34 | 39 | PF02516 | 0.417 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.610 |
MOD_NEK2_1 | 67 | 72 | PF00069 | 0.334 |
MOD_NEK2_2 | 15 | 20 | PF00069 | 0.521 |
MOD_OFUCOSY | 80 | 87 | PF10250 | 0.535 |
MOD_PKA_2 | 15 | 21 | PF00069 | 0.386 |
MOD_PKA_2 | 247 | 253 | PF00069 | 0.470 |
MOD_Plk_4 | 1 | 7 | PF00069 | 0.597 |
MOD_Plk_4 | 161 | 167 | PF00069 | 0.259 |
MOD_Plk_4 | 236 | 242 | PF00069 | 0.372 |
MOD_Plk_4 | 85 | 91 | PF00069 | 0.203 |
MOD_ProDKin_1 | 116 | 122 | PF00069 | 0.275 |
MOD_ProDKin_1 | 171 | 177 | PF00069 | 0.330 |
MOD_ProDKin_1 | 95 | 101 | PF00069 | 0.393 |
MOD_SUMO_rev_2 | 119 | 129 | PF00179 | 0.271 |
TRG_DiLeu_BaLyEn_6 | 69 | 74 | PF01217 | 0.334 |
TRG_ENDOCYTIC_2 | 209 | 212 | PF00928 | 0.449 |
TRG_ER_diArg_1 | 64 | 66 | PF00400 | 0.241 |
TRG_Pf-PMV_PEXEL_1 | 72 | 77 | PF00026 | 0.485 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1II02 | Leptomonas seymouri | 62% | 100% |
A0A0S4IVA9 | Bodo saltans | 37% | 83% |
A0A3S7WXK4 | Leishmania donovani | 73% | 78% |
A0A422N6B5 | Trypanosoma rangeli | 38% | 100% |
A4I085 | Leishmania infantum | 71% | 78% |
C9ZV01 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AW49 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 68% | 85% |
Q4QBC8 | Leishmania major | 69% | 100% |
V5BCE6 | Trypanosoma cruzi | 37% | 88% |